DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,561 | +32.1% | 2,731 | +27.8% | 0.27% | +34.2% |
| Q2 2023 | $512,880 | +8.0% | 2,137 | +13.4% | 0.20% | -2.0% |
| Q1 2023 | $474,843 | +10.0% | 1,884 | +15.9% | 0.20% | -1.0% |
| Q4 2022 | $431,573 | +24.0% | 1,626 | +20.5% | 0.20% | +13.3% |
| Q3 2022 | $348,000 | +2.7% | 1,349 | +1.0% | 0.18% | +5.8% |
| Q2 2022 | $339,000 | -12.6% | 1,336 | +1.1% | 0.17% | +8.9% |
| Q1 2022 | $388,000 | -21.8% | 1,322 | -81.1% | 0.16% | -44.3% |
| Q4 2021 | $496,000 | +17.8% | 7,013 | +406.7% | 0.28% | +54.1% |
| Q3 2021 | $421,000 | +8.8% | 1,384 | -4.1% | 0.18% | +8.3% |
| Q2 2021 | $387,000 | +20.2% | 1,443 | +0.8% | 0.17% | +11.2% |
| Q1 2021 | $322,000 | +5.9% | 1,431 | +4.5% | 0.15% | +1.3% |
| Q4 2020 | $304,000 | +3.8% | 1,370 | +0.5% | 0.15% | -8.5% |
| Q3 2020 | $293,000 | +20.1% | 1,363 | -20.1% | 0.16% | -4.7% |
| Q2 2019 | $244,000 | -2.4% | 1,705 | -10.1% | 0.17% | -9.0% |
| Q1 2019 | $250,000 | – | 1,897 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |